LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB
Publication
, Conference
McCarthy, PL; Holstein, SA; Jung, S-H; Cooper, M; Gibson, CJ; Stadtmauer, EA; Winograd, B; Richardson, P
Published in: HAEMATOLOGICA
June 26, 2017
Duke Scholars
Published In
HAEMATOLOGICA
ISSN
0390-6078
Publication Date
June 26, 2017
Volume
102
Start / End Page
108 / 108
Location
Madrid, SPAIN
Publisher
FERRATA STORTI FOUNDATION
Conference Name
22nd Congress of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
McCarthy, P. L., Holstein, S. A., Jung, S.-H., Cooper, M., Gibson, C. J., Stadtmauer, E. A., … Richardson, P. (2017). LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB. In HAEMATOLOGICA (Vol. 102, pp. 108–108). Madrid, SPAIN: FERRATA STORTI FOUNDATION.
McCarthy, P. L., S. A. Holstein, S. -. H. Jung, M. Cooper, C. J. Gibson, E. A. Stadtmauer, B. Winograd, and P. Richardson. “LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB.” In HAEMATOLOGICA, 102:108–108. FERRATA STORTI FOUNDATION, 2017.
McCarthy PL, Holstein SA, Jung S-H, Cooper M, Gibson CJ, Stadtmauer EA, et al. LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB. In: HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 108–108.
McCarthy, P. L., et al. “LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB.” HAEMATOLOGICA, vol. 102, FERRATA STORTI FOUNDATION, 2017, pp. 108–108.
McCarthy PL, Holstein SA, Jung S-H, Cooper M, Gibson CJ, Stadtmauer EA, Winograd B, Richardson P. LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB. HAEMATOLOGICA. FERRATA STORTI FOUNDATION; 2017. p. 108–108.
Published In
HAEMATOLOGICA
ISSN
0390-6078
Publication Date
June 26, 2017
Volume
102
Start / End Page
108 / 108
Location
Madrid, SPAIN
Publisher
FERRATA STORTI FOUNDATION
Conference Name
22nd Congress of the European-Hematology-Association
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology